Celliant ‘first of its kind’ to get nod from US FDA
27/07/2017
The US Food and Drug Administration (FDA) has determined Celliant products are medical devices and general wellness products, as they temporarily promote increased local blood flow at the site of application in healthy individuals. Seth Casden, CEO of Celliant maker Hologenix, said they are the first products of their kind that the FDA has...
Share this story:
